BioSpace News Archive

Anebulo Pharmaceuticals, Inc. today announced that it has agreed to sell an aggregate of 2,264,650 common shares and accompanying warrants to purchase up to 2,264,650 shares of common stock.

PerkinElmer, Inc. , (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca ® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow.

Relay Therapeutics, Inc. is scheduled to participate in a virtual fireside chat at the Bank of America Securities 2022 Precision Oncology Conference on Monday, October 3, 2022, at 2:50 p.m. ET.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced six upcoming presentations, including two presentations at the 2022 Inaugural HCM Society Scientific Sessions.

Actinium Pharmaceuticals, Inc. today announced that it will present at the Cantor Fitzgerald Oncology, Hematology & HemOnc Conference, which is being held on September 28th at the Lotte New York Palace Hotel.

TFF Pharmaceuticals, Inc. today announced that President and CEO Glenn Mattes will be participating in the Roth Inaugural Healthcare Opportunities Conference being held in-person at The Yale Club in New York City on October 6, 2022.

Daxor Corporation today announces it will be attending the Annual Scientific Meeting of the Heart Failure Society of America (HFSA) which brings together the world’s leading experts in heart failure at the Gaylord National Harbor in Washington, DC from September 30th thru October 3rd, 2022.

Cabaletta Bio, Inc. today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat at the Chardan 6th Annual Genetic Medicines Conference on Monday, October 3, 2022 at 4:00 p.m. ET in New York, NY.

Profound Medical Corp. announced that updated results from the TACT (TULSA-PRO® Ablation Clinical Trial) pivotal study were presented for the first time this past weekend, on Saturday, September 24, 2022, by Laurence Klotz, M.D., FRCSC, CM, Professor of Surgery, University of Toronto and Sunnybrook Chair of Prostate Cancer Research, at the FOCAL 2022 Conference held in Los Angeles, CA.

Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEWs™ line, a breakthrough RNA gene expression platform powered by Enzo’s LoopRNA™ in situ hybridization technology.